Rare diseases pose a significant challenge for health care professionals. These conditions — often complex and elusive — lead patients through a lengthy journey before a diagnosis is finally reached. The process is riddled with uncertainties, as symptoms usually mimic more common ailments.
Read full article in thr Journal od mHealth blog post here.
Akeso, a Chinese biotech that made headlines for beating Merck’s Keytruda in a head-to-head trial, won approval in China this week for the therapy, a company spokesperson confirmed to STAT. New data show early hints of the medicine improving patient…
From detecting TB, cancer, and heart attacks to diagnosing patients with strokes and diabetes, Artificial Intelligence (AI) is redefining the healthcare system across the world. Currently, more than 90% of hospitals and healthcare systems have implemented an AI or automation strategy,…